Okusaka T, Ikeda K, Kudo M, Finn R, et al. Safety and efficacy of lenvatinib by starting dose based on body weight in
patients with unresectable hepatocellular carcinoma in REFLECT. J Gastroenterol 2021 May 4. pii: 10.1007/s00535-021-01785.
PMID: 33948712